Advancing Patient Care using Point of Care Testing

Thursday, September 19, 2024 | 1:00pm - 2:00pm EST

In this webinar, Dr. Stephen Young will discuss the value of rapid antigen testing at the point-of-care. With over 40 years of academic and device trials experience in infectious disease, Dr. Young will share valuable insights on best diagnostic practices for this upcoming respiratory season.

More specifically, Dr. Young will explain how rapid diagnostic testing at the point-of-care (POC) can increase diagnostic confidence, guide treatment and management decisions, and improve patient outcomes.  

Webinar Speaker
Stephen Young.png


Stephen Young  
PhD D(ABMM)

  • Stephen Young, PhD D(ABMM), is a Medical Director for TriCore Research Institute’s Research and Clinical Trials Department. He is currently the Principal Investigator on 40 FDA clinical trials, primarily for SARS-CoV-2 EUA detection assays. Although most of the SARS-CoV-2 trials are still EUA, recent trials are switching to multiplex respiratory virus detection. In the last few years, the Device Trials team has completed over 150 trials, despite minimal IVD experience, continual supply chain issues and hurried timelines.
  • Prior to becoming the Medical Director at TRI in 2015, Dr. Young was the Scientific Director of the Infectious Disease section at TriCore Reference Laboratories for 17 years. He received his B.S. and M.S. in Biological Sciences from Wright State University and his PhD from the University of New Mexico (UNM). He completed an American Board of Medical Microbiology (ABMM) post-doctoral fellowship program at the University of Washington. Dr. Young has been a diplomat of the American Board of Medical Microbiology for the last 21 years and is a fellow of the American Association for the Advancement of Science.
  • Dr. Young is an Emeritus Professor in Pathology at UNM. For ten years he received funding from Sandia National Laboratories on the development of long-range sensors for biodefense. He has been a collaborator for 25 years in the Multi-Center AIDS Cohort Study, along with NIH grants affiliated with this cohort.
Register for the Webinar


The information contained in the webinars (“Webinar Content”) posted on this website represents the views and opinions of the featured medical professionals and does not necessarily represent the views or opinions of Henry Schein, Inc. (“Henry Schein”). The inclusion of Webinar Content on the website does not constitute an endorsement by Henry Schein or its affiliates of such Webinar Content or of any products, services, or procedures that may be depicted therein. The Webinar Content has been made available for informational and educational purposes only, and all medical decisions should be made by medical professionals in their independent judgment. As informational/educational material only, the Webinar Content is not intended for the purpose of promoting or recommending any specific, products, services, or procedures, or their uses or applications. Henry Schein does not make any representation or warranties with respect to the accuracy, applicability, fitness, or completeness of the Webinar Content. Henry Schein hereby disclaims any and all liability to any party for any direct, indirect, punitive, special, incidental or other consequential damages arising directly or indirectly from any use of the Webinar Content, which is provided as is, and without warranties.